Klarity, a global leader in advanced patient positioning devices, is pleased to announce an extended collaboration with Leo Cancer Care, a pioneering company in upright radiation therapy solutions. This partnership marks an exciting development in Klarity's commitment to providing state-of-the-art immobilization devices that enhance patient comfort and support during cancer treatment.

Patient motion control is of utmost importance in delivering precise radiation therapy to cancerous tumors, and Klarity has long been dedicated to developing innovative solutions that address this critical need. With an extensive range of products, including patient positioning devices, patient transfer system and SGRT system, Klarity is renowned for its advanced designs that prioritize patient safety and comfort.

Building upon its existing expertise, Klarity is thrilled to join forces with Leo Cancer Care to further enhance patient immobilization in the context of upright radiation therapy. Leo Cancer Care's unique upright patient positioning and CT imaging system, coupled with Klarity's expertise in developing high-quality immobilization devices, represents a significant step forward in improving the overall experience for patients undergoing treatment.

The collaboration between Klarity and Leo Cancer Care aligns with Klarity's mission to continuously innovate and provide cutting-edge solutions that improve the delivery of radiation therapy. By expanding its offerings to include compatible immobilization devices for upright treatments, Klarity aims to contribute to the growing field of radiation therapy and help healthcare providers deliver the highest standard of care to their patients.

Both Klarity and Leo Cancer Care will be showcasing their latest developments and prototypes at the upcoming ASTRO conference in San Diego on October 1-3. Visit Klarity booth 2317 and Leo Cancer Care booth 4207 to learn more about the innovative patient positioning solutions.